Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company EyeGene Inc.
DescriptionUndisclosed recombinant human protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetic retinopathy
Indication DetailsTreat non-proliferative diabetic retinopathy (NPDR)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today